Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Booth

Showing results (241-250 of 312) with videos related to

Pageof 32
Sort By:
Neuropharmacology|June 13, 2025
Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviorsJazmine D W Yaeger, Megan M John, Leighton J Ledesma, et al.
Circulation|September 6, 2006
Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapyKaisa M Mäki-Petäjä, Frances C Hall, Anthony D Booth, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 23, 1999
Quantitative and qualitative differences in the metabolism of 14C-1,3-butadiene in rats and mice: relevance to cancer susceptibilityK A Richardson, M M Peters, B A Wong, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Sortilin inhibition treats multiple neurodegenerative lysosomal storage disordersHannah G Leppert, Joelle T Anderson, Kaylie J Timm, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2020
AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten DiseaseTyler B Johnson, Katherine A White, Jon J Brudvig, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agentDavid J Boocock, Guy E S Faust, Ketan R Patel, et al.
Cancer Research|October 12, 2010
Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axisVictoria A Brown, Ketan R Patel, Maria Viskaduraki, et al.
Scientific Reports|December 31, 2024
Learned phenotypes emerge during social stress modifying hippocampal orexin receptor gene expressionJazmine D W Yaeger, Justin K Achua, Clarissa D Booth, et al.
Frontiers in Genetics|April 10, 2023
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 diseaseTyler B Johnson, Jon J Brudvig, Shibi Likhite, et al.
Cancer Research|September 16, 2010
Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patientsKetan R Patel, Victoria A Brown, Donald J L Jones, et al.
Pageof 32

Showing results (241-250 of 312) with videos related to

Sort By:
Pageof 32
Neuropharmacology|June 13, 2025
Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviorsJazmine D W Yaeger, Megan M John, Leighton J Ledesma, et al.
Circulation|September 6, 2006
Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapyKaisa M Mäki-Petäjä, Frances C Hall, Anthony D Booth, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 23, 1999
Quantitative and qualitative differences in the metabolism of 14C-1,3-butadiene in rats and mice: relevance to cancer susceptibilityK A Richardson, M M Peters, B A Wong, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Sortilin inhibition treats multiple neurodegenerative lysosomal storage disordersHannah G Leppert, Joelle T Anderson, Kaylie J Timm, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2020
AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten DiseaseTyler B Johnson, Katherine A White, Jon J Brudvig, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agentDavid J Boocock, Guy E S Faust, Ketan R Patel, et al.
Cancer Research|October 12, 2010
Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axisVictoria A Brown, Ketan R Patel, Maria Viskaduraki, et al.
Scientific Reports|December 31, 2024
Learned phenotypes emerge during social stress modifying hippocampal orexin receptor gene expressionJazmine D W Yaeger, Justin K Achua, Clarissa D Booth, et al.
Frontiers in Genetics|April 10, 2023
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 diseaseTyler B Johnson, Jon J Brudvig, Shibi Likhite, et al.
Cancer Research|September 16, 2010
Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patientsKetan R Patel, Victoria A Brown, Donald J L Jones, et al.
Pageof 32